Should we customize the treatment with interleukin‐17A inhibitors for moderate‐to‐severe psoriasis in the real‐world setting?
Von Automat
-
Kun Hu, Kun Hu Department of dermatology, Xiangya Hospital of Central South University, Changsha, China Search for more papers by this author Mi Zhang, Mi …